Precision Medicine in the Prostate Cancer Care Pathway
Recruiting
Observational Study
Prostate Cancer
Genetic Predisposition
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 30 – 70
- Sex
- Male
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- Institute of Cancer Research, United Kingdom · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the use of a prostate cancer specific predisposition genetic panel test in men with / at high risk of prostate cancer. The genetic test will analyse men's DNA samples for the presence of mutations in rare genes as well as common genetic variation to provide men with information about their risk of prostate cancer. This study will evaluate the clinical impact of the test…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Affected cohort:
1. Affected with PrCa \< 60 years or
2. Affected with metastatic castration resistant PrCa (mCRPC) at any age or Aggressive PrCa Gleason 4+4 or higher \<70 years
3. Affected with family history defined as three or more cases any age (FDR or SDR)
Unaffected coh…
Contacts
No contact information available.